One study demonstrated that Prdx1 inhibits the activation of oncogenes such as c-Abl and c-myc, and it can also be considered as a safeguard for the lipid phosphatase activity of PTEN, which is essential for its tumor-suppressive function (6). Here, PTEN is linked to neoplasm.